Novartis Poised for Growth as CEO Hands Baton to Successor Post author:Sam Post published:January 23, 2018 Post category:BioPharma Narasimhan takes over the role of CEO in February as current CEO Joe Jimenez retires. Source: BioSpace You Might Also Like CSL Behring Scoops Up This U.S. Biotech for $416 Million August 27, 2017 AcelRx Pharma Plans to Resubmit New Drug Application for Dsuvia March 8, 2018 Catabasis To Present Results From The Open-Label Extension Of The Movedmd Phase II Trial Of Edasalonexent In Duchenne Muscular Dystrophy In A Late Breaking Session Of The World Muscle Society September 14, 2017
Catabasis To Present Results From The Open-Label Extension Of The Movedmd Phase II Trial Of Edasalonexent In Duchenne Muscular Dystrophy In A Late Breaking Session Of The World Muscle Society September 14, 2017
